1. Significance of Understanding HBOC for At-Risk Relatives in Prostate and Pancreatic Cancer Patients Who Tested Positive on the Germline BRCA1/2 Genetic Testing in the Current Japanese Healthcare System
   Eriko Takamine, 2023, Practical Guide to Hereditary Breast and Ovarian Cancer CrossRef
2. DNA repair deficiency as circulating biomarker in prostate cancer
   Martina Catalano et al, 2023, Frontiers in Oncology CrossRef
3. Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer
   Fidelis Charles Bugoye et al, 2023, Frontiers in Genetics CrossRef
4. Effect of DNA damage response mutations on prostate cancer prognosis: a systematic review
   Stephanie L Swift et al, 2019, Future Oncology CrossRef
5. SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer
   Thorsten Schaefer et al, 2020, International Journal of Molecular Sciences CrossRef
6. Minimally Invasive Urology in the Reiwa Era
   Jun Akatsuka et al, 2022, Nihon Ika Daigaku Igakkai Zasshi CrossRef
7. Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis
   Tang Tang et al, 2020, Frontiers in Oncology CrossRef
8. Androgen Receptor-Mediated Transcription in Prostate Cancer
   Doğancan Özturan et al, 2022, Cells CrossRef
9. PARP-remmers bij gemetastaseerde prostaatkanker: een systematische review
   K. Kortbeek et al, 2022, Tijdschrift voor Geneeskunde CrossRef
10. Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease
    Edward J. Saunders et al, 2021, Cancers CrossRef
11. Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?
    Peter H. J. Slootbeek et al, 2024, Critical Reviews in Clinical Laboratory Sciences CrossRef
12. Prostate Cancer Tumor Stroma: Responsibility in Tumor Biology, Diagnosis and Treatment
    Luis O. González et al, 2022, Cancers CrossRef
13. A Case-Based Clinical Approach to the Investigation, Management and Screening of Families with BRCA2 Related Prostate Cancer
    Bradley King et al, 2021, The Application of Clinical Genetics CrossRef
14. Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis
    Pai-Chi Teng et al, 2021, International Journal of Molecular Sciences CrossRef
15. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine
    Filippo Marino et al, 2023, Prostate Cancer and Prostatic Diseases CrossRef
16. Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer
    O. A. Mailyan et al, 2021, Cancer Urology CrossRef
17. The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis
    Megan Crumbaker et al, 2020, Cancers CrossRef
18. Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer
    Yifeng Mao et al, 2022, Cancers CrossRef
19. Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers
    Kanako Hagio et al, 2023, Cancer Science CrossRef
20. Risk Assessment and Prevention Strategies for Hereditary Gynecological Cancers
    Sayaka Ueno et al, 2022, Personalization in Gynecologic Oncology CrossRef
21. PARP Inhibitors: A New Horizon for Patients with Prostate Cancer
    Belén Congregado et al, 2022, Biomedicines CrossRef